Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Locoregional Recurrence × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 459 Carcinoma, Non-Small-Cell Lung 434 Prostatic Neoplasms 294 Multiple Myeloma 233 Neoplasms 226 Colorectal Neoplasms 211 Leukemia, Myeloid, Acute 188 Squamous Cell Carcinoma of Head and Neck 182 Lung Neoplasms 178 Neoplasm Metastasis 171 Carcinoma, Hepatocellular 165 Pancreatic Neoplasms 158 Melanoma 151 Triple Negative Breast Neoplasms 142 Recurrence 129 Ovarian Neoplasms 129 Glioblastoma 117 Brain Neoplasms 115 Lymphoma 114 Leukemia, Lymphocytic, Chronic, B-Cell 106 Precursor Cell Lymphoblastic Leukemia-Lymphoma 105 Sarcoma 103 Lymphoma, Large B-Cell, Diffuse 103 Carcinoma, Renal Cell 103 Stomach Neoplasms 102 Head and Neck Neoplasms 102 Myelodysplastic Syndromes 92 Rectal Neoplasms 87 Endometrial Neoplasms 86 Urinary Bladder Neoplasms 83

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡